Business, News Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza by Business Wire • 2021/04/28 • 0 Comments GENEVA--(BUSINESS WIRE)--Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza Full Story →